Form 144 Filing: Insider to Sell 650 GDDY Shares Valued $91,741
Rhea-AI Filing Summary
Form 144 notice filed for proposed sale of common stock. The filing shows 650 shares of common stock proposed to be sold through Morgan Stanley Smith Barney LLC with an aggregate market value of $91,741.00. The proposed sale date is 08/13/2025 and the securities are listed on the NYSE. The filing also reports 138,449,017 shares outstanding.
The securities were acquired on 06/03/2025 as restricted stock from the issuer and paid on that same date. The form indicates Nothing to Report for securities sold during the past three months. Several identifying fields in the filing (including filer and issuer name entries in the provided text) are not populated in the content supplied. The signer represents they have no undisclosed material information and may indicate reliance on a trading plan if a plan adoption date is provided (none is shown).
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Form 144 for a small proposed insider sale; no material market-moving data reported.
The filing documents a proposed sale of 650 common shares through Morgan Stanley Smith Barney with an aggregate value of $91,741, scheduled for 08/13/2025. The shares were acquired as restricted stock on 06/03/2025. There are 138,449,017 shares outstanding per the filing. From a market-impact perspective, the size and dollar value disclosed are modest relative to the reported outstanding share count; the filing contains no disclosure of recent sales in the past three months. Several identification fields in the supplied content are blank, limiting attribution of the transaction to a specific insider within the document itself.
TL;DR: Disclosure appears procedurally correct but incomplete on identifying details; no governance red flags in provided text.
The notice includes the required representation regarding absence of undisclosed material information and references potential Rule 10b5-1 plan adoption, though no plan adoption date is shown. The acquisition and proposed sale dates are disclosed (06/03/2025 acquisition; 08/13/2025 proposed sale). The lack of populated filer/issuer name fields in the provided content reduces transparency for third-party review; otherwise the reported transaction follows standard Form 144 reporting elements.